Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy-Reference-Cited by-同舟云学术

Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy

Published:2020-09-18 Issue:11 Volume:21 Page:1084-1098
ISSN:1389-4501
Container-title:Current Drug Targets
language:en
Short-container-title:CDT

Author:

Chen Fengqian¹,Shi Yunzhen²,Zhang Jinming³,Liu Qi⁴

Affiliation:

1. Department of Environmental Toxicology, The Institute of Environmental and Human Health (TIEHH), Texas Tech University, Lubbock, TX 79416, United States

2. Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Macau, China

3. School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China

4. Department of Dermatology, Johns Hopkins University School of Medicine, Cancer Research Building II, Suite 216, 1550 Orleans Street, Baltimore, MD 21231, United States

Abstract

This review summarizes the epigenetic mechanisms of deoxyribonucleic acid (DNA) methylation, histone modifications in cancer and the epigenetic modifications in cancer therapy. Due to their undesired side effects, the use of epigenetic drugs as chemo-drugs in cancer therapies is limited. The drug delivery system opens a door for minimizing these side effects and achieving greater therapeutic benefits. The limitations of current epigenetic therapies in clinical cancer treatment and the advantages of using drug delivery systems for epigenetic agents are also discussed. Combining drug delivery systems with epigenetic therapy is a promising approach to reaching a high therapeutic index and minimizing the side effects.

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancement in Inhaled Nano-drug Delivery for Pulmonary, Nasal, and Nose-to-brain Diseases;Current Drug Delivery;2025-01

2. Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment;Biomedical Technology;2024-03

3. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements;Epigenomics;2023-04

4. Novel epigenetic therapeutic strategies and targets in cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2022-12

5. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment;Seminars in Cancer Biology;2022-11